Kevin Y. Xu, MD MPH
Division of Addiction Science, Prevention, and Treatment, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Washington University School of Public Health, St. Louis, Missouri
Review Article
Structural Racism and Telepsychiatry During the COVID-19 Pandemic
November 2, 2023
Data on whether psychiatry can be practiced effectively via telephone are lacking. This study examined the racial and sociodemographic distribution of people receiving audiovisual versus audio-only telepsychiatry since the...
Original Research
Association of Bupropion and Opioid Use Disorder Medications With Stimulant-Related Admissions
June 20, 2022
This study investigated whether bupropion and OUD medications (buprenorphine, naltrexone, and methadone) are associated with decreased stimulant-related ED admissions and hospitalizations in people with OUD who had at least...
